Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marc Tischkowitz

Showing results (41-50 of 258) with videos related to

Pageof 26
Sort By:
Nature Medicine|April 15, 2003
Disruption of the Fanconi anemia-BRCA pathway in cisplatin-sensitive ovarian tumorsToshiyasu Taniguchi, Marc Tischkowitz, Najim Ameziane, et al.
American Journal of Obstetrics and Gynecology|June 26, 2023
Long-term outcomes of hysterectomy with bilateral salpingo-oophorectomy: a systematic review and meta-analysisHend Hassan, Isaac Allen, Eleni Sofianopoulou, et al.
Plos One|December 2, 2021
Assessing BRCA1 activity in DNA damage repair using human induced pluripotent stem cells as an approach to assist classification of BRCA1 variants of uncertain significanceMeryem Ozgencil, Julian Barwell, Marc Tischkowitz, et al.
Nature|October 5, 2022
Nuclear-embedded mitochondrial DNA sequences in 66,083 human genomesWei Wei, Katherine R Schon, Greg Elgar, et al.
BMC Medical Genetics|January 11, 2013
Contribution of the PALB2 c.2323C>T [p.Q775X] founder mutation in well-defined breast and/or ovarian cancer families and unselected ovarian cancer cases of French Canadian descentMarc Tischkowitz, Nelly Sabbaghian, Nancy Hamel, et al.
Pediatric Blood & Cancer|October 14, 2014
Biallelic somatic SMARCA4 mutations in small cell carcinoma of the ovary, hypercalcemic type (SCCOHT)Shivani Bailey, Matthew J Murray, Leora Witkowski, et al.
BJC Reports|November 8, 2024
Patterns of referrals to regional clinical genetics services for women potentially at above-population level risk of breast cancerJuliet A Usher-Smith, Georgia Tooth, Annabel Follows, et al.
Familial Cancer|July 17, 2015
Risk reducing salpingectomy and delayed oophorectomy in high risk women: views of cancer geneticists, genetic counsellors and gynaecological oncologists in the UKDhivya Chandrasekaran, Usha Menon, Gareth Evans, et al.
Eclinicalmedicine|July 11, 2026
Predictors of early cancer burden in <i>CDH1</i> pathogenic variant carriers: a UK single-centre cohort studyLianlian Wu, Hui Jun Lim, Nandini Karthik, et al.
Medrxiv : the Preprint Server for Health Sciences|April 10, 2026
Genomic ascertainment of <i>PALB2</i> -related cancer predispositionDouglas R Stewart, Jung Kim, Jeremy S Haley, et al.
Pageof 26

Showing results (41-50 of 258) with videos related to

Sort By:
Pageof 26
Nature Medicine|April 15, 2003
Disruption of the Fanconi anemia-BRCA pathway in cisplatin-sensitive ovarian tumorsToshiyasu Taniguchi, Marc Tischkowitz, Najim Ameziane, et al.
American Journal of Obstetrics and Gynecology|June 26, 2023
Long-term outcomes of hysterectomy with bilateral salpingo-oophorectomy: a systematic review and meta-analysisHend Hassan, Isaac Allen, Eleni Sofianopoulou, et al.
Plos One|December 2, 2021
Assessing BRCA1 activity in DNA damage repair using human induced pluripotent stem cells as an approach to assist classification of BRCA1 variants of uncertain significanceMeryem Ozgencil, Julian Barwell, Marc Tischkowitz, et al.
Nature|October 5, 2022
Nuclear-embedded mitochondrial DNA sequences in 66,083 human genomesWei Wei, Katherine R Schon, Greg Elgar, et al.
BMC Medical Genetics|January 11, 2013
Contribution of the PALB2 c.2323C>T [p.Q775X] founder mutation in well-defined breast and/or ovarian cancer families and unselected ovarian cancer cases of French Canadian descentMarc Tischkowitz, Nelly Sabbaghian, Nancy Hamel, et al.
Pediatric Blood & Cancer|October 14, 2014
Biallelic somatic SMARCA4 mutations in small cell carcinoma of the ovary, hypercalcemic type (SCCOHT)Shivani Bailey, Matthew J Murray, Leora Witkowski, et al.
BJC Reports|November 8, 2024
Patterns of referrals to regional clinical genetics services for women potentially at above-population level risk of breast cancerJuliet A Usher-Smith, Georgia Tooth, Annabel Follows, et al.
Familial Cancer|July 17, 2015
Risk reducing salpingectomy and delayed oophorectomy in high risk women: views of cancer geneticists, genetic counsellors and gynaecological oncologists in the UKDhivya Chandrasekaran, Usha Menon, Gareth Evans, et al.
Eclinicalmedicine|July 11, 2026
Predictors of early cancer burden in <i>CDH1</i> pathogenic variant carriers: a UK single-centre cohort studyLianlian Wu, Hui Jun Lim, Nandini Karthik, et al.
Medrxiv : the Preprint Server for Health Sciences|April 10, 2026
Genomic ascertainment of <i>PALB2</i> -related cancer predispositionDouglas R Stewart, Jung Kim, Jeremy S Haley, et al.
Pageof 26